TECARTUS
TECARTUS
Approved
DIN Number
02532719
Drug Class
Human
Market Date
Dec 15, 2023
Company
HC
gilead sciences canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02532719
AIG Number0162968002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01XL06 BREXUCABTAGENE AUTOLEUCEL
Product Specifications
Dosage FormSuspension
Route of AdministrationIntravenous
AHFS Classification26:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
BREXUCABTAGENE AUTOLEUCELActive
Strength: 100000000 CELLS / BAG
Monograph: BREXUCABTAGENE AUTOLEUCEL